Day One Biopharmaceuticals DAWN Stock
Day One Biopharmaceuticals Price Chart
Day One Biopharmaceuticals DAWN Financial and Trading Overview
| Day One Biopharmaceuticals stock price | 7.74 USD |
| Previous Close | 13.47 USD |
| Open | 13.44 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 900 |
| Day's Range | 12.86 - 13.48 USD |
| 52 Week Range | 10.84 - 28.35 USD |
| Volume | 1.37M USD |
| Avg. Volume | 1.2M USD |
| Market Cap | 1.14B USD |
| Beta (5Y Monthly) | -2.082746 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 40.67 USD |
DAWN Valuation Measures
| Enterprise Value | 673.56M USD |
| Trailing P/E | N/A |
| Forward P/E | -6.441177 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.218222 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -4.083 |
Trading Information
Day One Biopharmaceuticals Stock Price History
| Beta (5Y Monthly) | -2.082746 |
| 52-Week Change | -16.78% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 28.35 USD |
| 52 Week Low | 10.84 USD |
| 50-Day Moving Average | 13.15 USD |
| 200-Day Moving Average | 18.44 USD |
DAWN Share Statistics
| Avg. Volume (3 month) | 1.2M USD |
| Avg. Daily Volume (10-Days) | 2.44M USD |
| Shares Outstanding | 86.84M |
| Float | 46.89M |
| Short Ratio | 10.72 |
| % Held by Insiders | 29.28% |
| % Held by Institutions | 82.30% |
| Shares Short | 10M |
| Short % of Float | 24.05% |
| Short % of Shares Outstanding | 13.58% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -34.88% |
| Return on Equity (ttm) | -56.0080% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -164952992 USD |
| Net Income Avi to Common (ttm) | -156827008 USD |
| Diluted EPS (ttm) | -2.45 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 318.18M USD |
| Total Cash Per Share (mrq) | 4.33 USD |
| Total Debt (mrq) | 717K USD |
| Total Debt/Equity (mrq) | 0.24 USD |
| Current Ratio (mrq) | 14.11 |
| Book Value Per Share (mrq) | 4.083 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -114296000 USD |
| Levered Free Cash Flow (ttm) | -57264000 USD |
Profile of Day One Biopharmaceuticals
| Country | United States |
| State | CA |
| City | Brisbane |
| Address | 2000 Sierra Point Parkway |
| ZIP | 94005 |
| Phone | 650 484 0899 |
| Website | https://dayonebio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 125 |
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
Q&A For Day One Biopharmaceuticals Stock
What is a current DAWN stock price?
Day One Biopharmaceuticals DAWN stock price today per share is 7.74 USD.
How to purchase Day One Biopharmaceuticals stock?
You can buy DAWN shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Day One Biopharmaceuticals?
The stock symbol or ticker of Day One Biopharmaceuticals is DAWN.
Which industry does the Day One Biopharmaceuticals company belong to?
The Day One Biopharmaceuticals industry is Biotechnology.
How many shares does Day One Biopharmaceuticals have in circulation?
The max supply of Day One Biopharmaceuticals shares is 103.45M.
What is Day One Biopharmaceuticals Price to Earnings Ratio (PE Ratio)?
Day One Biopharmaceuticals PE Ratio is now.
What was Day One Biopharmaceuticals earnings per share over the trailing 12 months (TTM)?
Day One Biopharmaceuticals EPS is -1.02 USD over the trailing 12 months.
Which sector does the Day One Biopharmaceuticals company belong to?
The Day One Biopharmaceuticals sector is Healthcare.
Day One Biopharmaceuticals DAWN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 2065.14 USD — |
-0.04
|
— — | 2039.56 USD — | 2065.23 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4148.65 USD — |
+0.54
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 8504.39 USD — |
+1.34
|
— — | 8367.19 USD — | 8515.13 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4131.38 USD — |
-1.41
|
— — | 4109.33 USD — | 4165.2 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 923.51 USD — |
-0.73
|
— — | 917.75 USD — | 925.61 USD — | — - | — — |
- {{ link.label }} {{link}}